Literature DB >> 9207443

Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera.

S Chiba1, T Takahashi, K Takeshita, J Minowada, Y Yazaki, F H Ruddle, H Hirai.   

Abstract

The mRNA encoding full-length erythropoietin (EPO) receptor (EPOR-F) comprises exons I through VIII. Another membrane-bound EPOR (EPOR-T) isoform has a truncated cytoplasmic region and is encoded by the mRNA containing unspliced intron VII (EPOR-T mRNA). EPOR-T is believed to have a dominantly negative function against EPOR-F. We show that EPOR-T mRNA is markedly decreased in the blood cells of patients with polycythemia vera (PV). We also show that EPOR-T mRNA is not detected in erythroid/megakaryocytic leukemia cell lines, but is expressed in nonerythroid/nonmegakaryocytic lines, suggesting the presence of a cell type-specific system by which intron VII of the EPOR transcript is spliced. Deregulation of this splicing system in early hematopoietic progenitors possibly explains the profound decrease in EPOR-T mRNA and consequent pathophysiology of PV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207443

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Basic sciences of the myeloproliferative diseases: pathogenic mechanisms of ET and PV.

Authors:  Rosemary E Gale
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.

Authors:  Natalia A Kokorina; Celine J Granier; Stanislav O Zakharkin; Stephani Davis; Arnold B Rabson; Hatem E Sabaawy
Journal:  Exp Hematol       Date:  2012-08-22       Impact factor: 3.084

3.  c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance.

Authors:  Fei Li; Yuanyan Xiong; Mo Yang; Peiling Chen; Jingkai Zhang; Qiong Wang; Miao Xu; Yiming Wang; Zuyong He; Xin Zhao; Junyu Huang; Xiaoqiong Gu; Li Zhang; Rui Sun; Xunsha Sun; Jingyao Li; Jinxin Ou; Ting Xu; Xueying Huang; Yange Cao; Xiaohong Ruby Xu; Danielle Karakas; June Li; Heyu Ni; Qing Zhang
Journal:  Cell Death Dis       Date:  2022-10-13       Impact factor: 9.685

4.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.